Global Medical REIT (GMRE) PT Raised to $16 at Stifel, After Equity Offering Announcement
- Boeing, travel stocks pull Wall Street lower as virus cases rise
- Kansas City Southern (KSU) Soars as Bidding War Brews After Canadian National Railway (CNI) Makes a $33.7 Billion Offer
- Analysts Positive, Raise PTs as IBM (IBM) Tops Market Estimates and Reaffirms Guidance
- Boeing (BA) Down 3% After CFO - Aged 54 - Retires, Seen as an 'Odd' Move
- Tesla (TSLA): Problems in China Mounting as Communist Party Officials Ask Company to 'Respect Chinese Consumers and Comply with Local Laws'
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Stifel analyst Stephen Manaker raised the price target on Global Medical REIT (NYSE: GMRE) to $16.00 (from $15.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- bluebird bio (BLUE) PT Lowered to $29 at Stifel
- VAT Group AG (VACN:SW) PT Raised to CHF315 at Berenberg
- Brewin Dolphin Holdings Plc. (BRW:LN) (BDNHF) PT Raised to GBP3.90 at Berenberg
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!